IngredientesLa aloína, un compuesto de origen natural que se encuentra principalmente en el látex del Aloe vera y especies de Aloe relacionadas, tiene una rica historia de uso medicinal que se remonta a miles de años. Las civilizaciones antiguas, incluidas la egipcia, la griega y la romana, reconocieron el potencial terapéutico del Aloe, utilizando su látex para una variedad de dolencias. La aloína, como el principal glucósido antraquinónico en el látex de Aloe, era especialmente valorada por sus potentes propiedades laxantes. Los remedios tradicionales a menudo implicaban extractos que contenían aloína para aliviar el estreñimiento, apoyar la salud digestiva y purificar el cuerpo. En la Edad Media, las preparaciones de Aloe ricas en aloína eran ampliamente comercializadas y consideradas esenciales en las boticas de toda Europa y el Medio Oriente.
Más allá de su papel como remedio independiente, la aloína ha sido frecuentemente incorporada en combinaciones herbales para mejorar la eficacia general. Los herbolarios a menudo mezclaban el látex de Aloe con otras plantas botánicas como la sen, la cáscara sagrada y la raíz de ruibarbo para crear fórmulas sinérgicas para el bienestar digestivo y la limpieza del colon. Estas combinaciones no solo amplificaban el efecto laxante, sino que también equilibraban la acción, reduciendo el malestar y apoyando la salud intestinal. La versatilidad de la aloína se extendía también a las aplicaciones tópicas, donde a veces se combinaba con hierbas curativas para el cuidado de heridas y afecciones de la piel.
En general, las contribuciones históricas de la aloína en la medicina tradicional han sido significativas. Su inclusión en los remedios herbales ha proporcionado un apoyo confiable para los procesos digestivos y de desintoxicación, reforzando su estimado estatus en las prácticas de salud natural a través de culturas y generaciones.
La aloína es un compuesto de origen natural derivado del látex de la planta Aloe vera, que se encuentra principalmente en la savia amarillenta justo debajo de la piel de la hoja. Históricamente, el Aloe ha sido utilizado por sus propiedades medicinales que se remontan al antiguo Egipto, Grecia y Roma, donde era apreciado como agente curativo para dolencias de la piel y problemas digestivos. La aloína, el principal glucósido antraquinónico presente en el látex de Aloe, ha sido utilizada tradicionalmente como laxante estimulante, ayudando en los movimientos intestinales y aliviando el estreñimiento.
La investigación científica ha explorado las actividades farmacológicas de la aloína, señalando que su efecto laxante se debe a la estimulación del peristaltismo intestinal y a la prevención de la reabsorción de agua en el colon. Algunos estudios in vitro y en animales también han sugerido propiedades antioxidantes, antiinflamatorias y antimicrobianas, que pueden contribuir al uso tradicional del Aloe en el apoyo a la salud digestiva e inmunológica. Sin embargo, los estudios clínicos en humanos son limitados, y las autoridades reguladoras en algunas regiones han restringido el uso de productos que contienen aloína debido a preocupaciones sobre posibles efectos secundarios con el uso crónico, como el desequilibrio electrolítico.
A pesar de estas limitaciones, la aloína continúa siendo un componente en ciertos productos nutricionales y herbales, particularmente aquellos orientados al apoyo digestivo. Si bien la eficacia y seguridad de la aloína para el uso a largo plazo requieren una validación clínica sólida adicional, su uso histórico y los hallazgos científicos preliminares destacan su valor potencial. El uso responsable de productos que contienen aloína, siguiendo las pautas de dosificación y bajo supervisión profesional, puede ofrecer beneficios como parte de un enfoque holístico para la salud digestiva.
Condiciones de salud que L-glicina puede ayudar a apoyar.
Glycine is an obligate precursor for glutathione (GSH), the most abundant intracellular antioxidant and a key molecule in cellular detoxification and redox regulation. GlyNAC clinical trials demonstrate that glycine supplementation restores GSH deficiency and corrects oxidative stress in older adults, HIV patients, and metabolic disease states.
Clinical trials show that 3 g of glycine taken before bedtime significantly reduces self-reported anxiety levels the following morning. Glycine acts as an inhibitory neurotransmitter, dampening neural excitability via strychnine-insensitive glycine receptors. Evidence comes from small controlled studies in individuals with poor sleep and insomniac tendencies.
Glycine is essential for the synthesis of type II collagen, the major structural protein in articular cartilage degraded in arthritis. It also reduces pro-inflammatory cytokine production (TNF-alpha, IL-6) and NF-κB activation, which drive synovial inflammation. Clinical trials of glycine-rich collagen peptides show improvements in joint pain and function in osteoarthritis patients.
Clinical trials in metabolic syndrome patients show that glycine supplementation at 5–15 g/day reduces systolic blood pressure. The GlyNAC 16-week RCT in older adults also documented improvement in blood pressure alongside other aging-related defects. Mechanistically, glycine improves endothelial function and reduces vascular inflammation.
Lower circulating glycine is consistently observed in type 2 diabetes and obesity, and clinical trials suggest glycine supplementation can improve fasting glucose and postprandial glycemic control. A 5 g oral dose has been shown to increase insulin secretory responses, and RCT evidence supports modest reductions in HbA1c in metabolic syndrome patients. Effects are adjunctive rather than pharmacological.
Glycine is an established inhibitory neurotransmitter in the spinal cord and brainstem, and its ingestion promotes subjective feelings of calm and relaxation. Human clinical studies using 3 g before bedtime report reduced daytime fatigue and improved tranquility scores. The mechanism involves both glycine receptor-mediated neuronal inhibition and reductions in core body temperature.
Glycine constitutes approximately one-third of all amino acid residues in collagen, which forms the structural matrix of cartilage. Adequate glycine is rate-limiting for collagen synthesis, and deficiency impairs maximal collagen production. While most direct evidence comes from biochemical and in vitro work, clinical trials of collagen peptides (which are glycine-rich) support cartilage and joint matrix support.
Glycine supports cellular energy through multiple pathways: it contributes to mitochondrial glutathione that protects respiratory chain function, participates in creatine synthesis (with arginine) for phosphocreatine energy buffering, and is a substrate in the glycine cleavage system that feeds one-carbon units into folate metabolism used in ATP production. GlyNAC RCTs demonstrate correction of mitochondrial fuel oxidation.
Glycine inhibits pro-inflammatory cytokine production including TNF-alpha and IL-6 and suppresses NF-κB pathway activation. GlyNAC (glycine + N-acetylcysteine) RCT evidence in older adults demonstrates significant reduction in inflammatory markers. Glycine also modulates Kupffer cell and macrophage activity in the liver, reducing inflammatory responses.
GlyNAC supplementation in multiple clinical trials in older adults demonstrates significant improvements in cognitive function, including Montreal Cognitive Assessment (MoCA) scores, alongside reversal of oxidative stress, mitochondrial dysfunction, and inflammation that drive age-related cognitive decline. Glycine's role as an NMDA co-agonist further supports synaptic plasticity relevant to cognitive aging.
Glycine is the most abundant amino acid in collagen (approximately one-third of all collagen residues) and is required as every third amino acid in the Gly-X-Y triplet repeat that forms the collagen triple helix. Supplemental glycine supports collagen synthesis in all connective tissues and has been used in wound healing and recovery protocols.
Oral glycine administration acutely stimulates pituitary growth hormone (GH) secretion in a dose-dependent manner. A bolus of 22.5 g has been reported to cause a ~60% surge in GH levels within minutes. Smaller doses of 4–12 g also raise serum GH in a dose-dependent fashion, per early pharmacological studies.
GlyNAC (glycine + N-acetylcysteine) supplementation in multiple RCTs in older adults corrects glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, and insulin resistance—all hallmarks of aging. These trials show measurable improvements in physical function, muscle strength, and cognitive performance. Collagen-amino acid ratio supplementation containing glycine also reduced biological age in a clinical observational trial.
Multiple controlled clinical trials demonstrate that 3 g of oral glycine before bedtime improves both subjective and objective sleep quality in individuals with insomnia or insomniac tendencies. Polysomnographic studies confirm reduced sleep onset latency, shorter time to slow-wave sleep, and improved sleep efficiency. The mechanism involves peripheral vasodilation causing a drop in core body temperature that facilitates sleep initiation.
Low plasma glycine is a robust biomarker of insulin resistance, and multiple clinical studies show glycine supplementation improves insulin secretion, sensitivity, and postprandial glucose control. GlyNAC RCTs also demonstrate correction of insulin resistance in older adults. Mechanistically, glycine may enhance GLP-1 secretion and improve pancreatic beta-cell function.
L-glycine is the supplemental form of glycine, an amino acid with documented anti-inflammatory effects on intestinal epithelial cells and essential roles in glutathione synthesis and collagen/ECM production for gut lining integrity. Authoritative leaky gut ingredient reviews identify glycine-related amino acids as critical for gut healing, and glycine is included in evidence-based gut-healing amino acid protocols alongside glutamine and proline.
Glycine is a direct precursor of glutathione (γ-L-glutamyl-L-cysteinyl-glycine), the liver's principal endogenous detoxification antioxidant. Glycine also participates directly in hepatic phase II conjugation (glycine conjugation), detoxifying bile acids and aromatic compounds. Animal studies show hepatoprotective effects, and small clinical trials suggest benefit in chronic hepatitis and fatty liver disease.
Glycine is an obligate co-agonist at NMDA receptors, which are central to synaptic plasticity and memory consolidation. Clinical RCTs with GlyNAC in older adults show measurable improvements in cognitive function including memory. Glycine sleep studies also document improvements in memory recognition tasks the morning after supplementation.
Plasma glycine is consistently lower in metabolic syndrome patients than in healthy controls. A published review of clinical and preclinical evidence concludes that glycine supplementation improves multiple components of metabolic syndrome including hyperglycemia, hypertension, hyperlipidemia, and obesity-related inflammation. RCTs document reductions in HbA1c, CRP, and blood pressure.
GlyNAC supplementation (glycine + N-acetylcysteine) has demonstrated in controlled clinical trials that it corrects mitochondrial fuel oxidation defects in older adults. Glycine's role as a glutathione precursor is central: GSH deficiency impairs mitochondrial function, and restoring GSH via GlyNAC reverses mitochondrial dysfunction. Multiple RCTs confirm improvements in mitochondrial fatty-acid oxidation.
Glycine contributes to muscle recovery by suppressing proteolytic gene expression, activating anabolic signaling pathways (Akt-mTOR-FOXO1), and reducing post-exercise inflammation via inhibition of NF-κB and pro-inflammatory cytokines. It also contributes to creatine synthesis via arginine-glycine amidinotransferase. Evidence is primarily from cell and animal studies, with limited human RCT data.
Glycine is itself a major inhibitory neurotransmitter in the spinal cord and brainstem, activating strychnine-sensitive glycine receptors (GlyRs). It is also an obligate co-agonist at excitatory NMDA glutamate receptors, making it unique in modulating both inhibitory and excitatory neurotransmission. High-dose glycine clinical trials have demonstrated restoration of NMDA receptor function in schizophrenia patients.
L-Glycine is the most abundant amino acid in collagen and is essential for wound healing, tissue protection, and immunity post-surgically. Scientific reviews confirm glycine contributes to protein synthesis, wound repair, and immune response. Collagen peptides rich in glycine have demonstrated clinical benefits in multiple post-surgical healing trials.
Glycine is a primary structural amino acid in collagen, required for postpartum wound healing and tissue repair. A US patent on postpartum recovery formulas specifically cites glycine (alongside proline and vitamin C) as a collagen-supporting nutrient for postpartum wound healing and connective tissue restoration. It is included in expert postnatal formulas for this purpose.
Glycine is the most abundant amino acid in skin collagen (approximately one-third of all residues) and is rate-limiting for collagen synthesis. Clinical trials of glycine-rich collagen peptide supplements show significant reductions in wrinkle depth, improved skin hydration, and increased elasticity. A collagen amino acid composition containing glycine also reduced biological skin age in a controlled observational trial.
Glycine is the most abundant amino acid in collagen (~33% of residues, occupying every third position in the Gly-X-Y repeat). In dermal fibroblasts, glycine is superior to proline, glutamine, and leucine at increasing collagen synthesis. A 2025 in vivo study showed atelocollagen enhanced collagen synthesis in aged mouse skin through GlyT1-dependent glycine transport, increasing collagen density and skin elasticity.
Controlled clinical trials and polysomnographic studies demonstrate that 3 g of glycine before bedtime shortens sleep onset latency and reduces time to slow-wave sleep. The mechanism involves NMDA receptor-mediated activation in the suprachiasmatic nucleus, inducing peripheral vasodilation and a drop in core body temperature that facilitates rapid sleep initiation.
Glycine is a non-essential amino acid that subjectively and objectively improves sleep quality in individuals with insomnia or restricted sleep. Human RCTs at 3 g before bedtime found improved PSQI scores, reduced sleep latency, increased slow-wave sleep, and reduced daytime fatigue. The mechanism involves NMDA receptor modulation in the suprachiasmatic nucleus causing peripheral vasodilation and body temperature lowering, which promotes sleep onset.
A PubMed review of glycine's effects on metabolic syndrome components concludes that glycine supplementation improves hyperlipidemia, including elevated triglycerides, alongside other components of metabolic syndrome. Lower plasma glycine is consistently found in metabolic syndrome patients, and supplementation partially reverses this defect.
Glycine is an obligate structural component of collagen (one-third of residues), which is essential for wound closure and tissue remodeling. In vitro, glycine enhances collagen production in human dermal fibroblasts. Animal and human clinical evidence with collagen-based interventions supports accelerated wound healing, reduced infection, and better tissue regeneration.
Sistemas corporales que L-glicina puede ayudar a apoyar.
Volver